Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength

Weimin Yao; Weiwei Dai; Li Jiang; Evan Yu-An Lay; Zhendong Zhong; Robert O. Ritchie; X. Li; Hua Zhu Ke; N.E. Lane

doi:10.1007/s00198-015-3308-6

Related publications

Article2014

Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass

Sarah Amugongo, Wei Yao, Jing Jia, Y.-A. E. Lay, Weiwei Dai, Li Jiang, David A. Walsh, C.-S. Li, Neil K. N. Dave, D.L. Olivera, Brian Panganiban, Robert O. Ritchie, Nancy E. Lane

Osteoporosis International

Article2007

Pharmacologic enhancement of bone strength by statins

Gloria E. Gutierrez, Jeffry S. Nyman, I. Ross Garrett, Edwards, Brandon McCluskey, G. Rossini, Tamara Alliston, С. А. Ионова, Robert O. Ritchie, Andressa Flores, G R Mundy

Bone

Article1994

Physical activity, fitness, and osteoporosis.

Barbara L. Drinkwater, Claude Bouchard, Roy J. Shephard, T.W. Stephens

Article2005

Reliability Analysis of Maintained Ships Under Correlated Fatigue and Corrosion

Xie Jiang, Robert Melchers

The International Journal of Maritime Engineering

Article2015

The fracture mechanics of human bone: influence of disease and treatment

Elizabeth A. Zimmermann, Björn Busse, Robert O. Ritchie

BoneKEy Reports